ZoeNCure Therapeutics Secures INR 20 Crore Seed Investment to Accelerate Next-Generation Antibody Drug Conjugate (ADC) Program

Follow-on investment led by the HNI (High-Net-Worth Individual) Tyagi Family bringing total capital raised to date to INR 22.5 Crore, underscoring strong investor confidence in ZoeNCure.